text:
< Return To Hearing
The Hon. Billy Tauzin
Testimony of Mr. Billy Tauzin before the Senate Committee on the Judiciary Chairman Leahy, Ranking Member Specter, and Members of the Committee: Thank you for the invitation to participate in today's hearing on pharmaceutical companies' settlements of patent disputes. My name is Billy Tauzin and I am the President and Chief Executive Officer of the Pharmaceutical Research and Manufacturers of America (PhRMA). PhRMA represents the country's leading research-based pharmaceutical and biotechnology companies, which are devoted to developing medicines that allow patients to lead longer, healthier, and more productive lives. Our member companies invested more than $39 billion in 2005 discovering and developing new medicines. PhRMA companies are leading the way in the search for new and better treatments for patients. As most of you know, I have a very personal reason to be deeply grateful to the thousands of men and women who work every day to bring these new medicines to patients. Because I too have been a patient. Just about three years ago, I was diagnosed with cancer, and I left Congress to battle that disease. Today, with support from family and friends and the help of some amazing doctors and nurses, I am now a cancer survivor. I also know that I would not be here now without the help of the innovative medicines made by America's research-based biopharmaceutical companies. Because of those medicines, I am cancer free and living a healthy, full life. Ten years ago - even five years ago - that might not have been true. Some of the medicines that helped save my life would still have been in the development process then. It took the efforts of innovative pharmaceutical companies willing to risk money, time, resources and manpower to get these medicines all the way through the regulatory approval process and into the hands of physicians and patients. And because of these efforts, patients like me everywhere are better off. In order to foster these much-needed medical breakthroughs, we must continue to pursue public policies that provide for strong patents - patents that allow pharmaceutical companies and their investors an opportunity to recoup and secure the benefits of their significant investments. This testimony will address the importance of patents to pharmaceutical innovation and the importance of preserving options to reach pro-consumer settlements of expensive and time consuming patent litigation among brand and generic pharmaceutical companies. Courts and experts have stated unequivocally that settlement of litigation should be encouraged and that settlement of patent litigation can benefit consumers. Blanket prohibitions on certain types of settlements could force both sides to spend valuable resources litigating their patent dispute to judgment. Statistics show that innovators will win a significant number of those cases, and a win by the patent holder means the generic likely would not be able to enter the market before the patent expires. In addition, both innovators and generics would have to absorb - or pass on to consumers - the costs of increased litigation. In the face of these alternatives, it is better for companies, the courts and consumers if the parties are permitted to negotiate settlements that could bring the generic product to consumers before the patent expires and save considerable litigation costs. A total ban on settlements in which the brand company gives something of value to the generic could stop pro-consumer settlements, reduce the value of patents, and reduce incentives for innovation. The sweeping prohibition could also have the unintended consequence of reducing generic companies' incentives to challenge patents in the first place, as they will have to consider that their options of settling patent litigation will be dramatically reduced. Instead of an across-the-board ban, enforcement agencies and courts should continue to evaluate patent settlements on a case-by-case basis, looking at all relevant facts including the scope of the patent. In the Medicare Modernization Act, Congress gave the FTC and the Department of Justice the authority and ability to evaluate patent settlement agreements between brand and generic companies before the generic is due to come on the market. This approach will give the agencies and courts the chance to consider all the relevant facts and circumstances and address settlements that would harm consumers without eliminating those that will promote competition. I. Patents Are Essential To Pharmaceutical Innovation Intellectual property protection has deep roots in the United States, all the way back to the protection authorized by Article I of the U.S. Constitution. Patents are crucial because they make it possible for society to realize or secure the benefits of genius, creativity and effort. Since our patent system was created in 1790, it has been key to critical advances in science and technology - think of life without the plow, the steam engine, the jet engine, the laptop computer, the wireless phone or fiber optic cable, to name a few. Of all of the advances in the last century, from aviation to the Internet, few have been as important and valuable to the preservation and enhancement of life as pharmaceutical innovations. According to University of Chicago economists, "Over the last half century, improvements in health have been as valuable as all other sources of economic growth combined."1 Patents are given due respect in the law. By Congressional enactment, an issued patent is afforded the presumption of validity.2 In the antitrust context, courts have held that the antitrust laws should be interpreted not to supplant the patent right.3 Indeed, courts recognize that antitrust and intellectual property are ''two bodies of law [that] are actually complementary, as both are aimed at encouraging innovation, industry, and competition."ll Consistent Withthe antitrust laws, a patent holder may exclude others from producing a patented article, or may grant limited Iicenses.5 Generally, only when a restriction on use goes "outside the scope of the patent granf' are the antitrust laws implicated.6 Innovators across industries rely on patents to ensure that their inventions are protected and that they will be given an opportunity to recover their research investments. Strong intellectual property protection is essential for the preservation and growth of the research-based pharmaceutical industry. It takes on average 10-15 years and more than $800 million, according to the Tufts Center for the Study of Drug Development, to bring a new medicine to consumers.7 Let's take Gleevec?, for example, the breakthrough treatment for chronic myeloid leukemia that won PhRMA's Discover's Award in 2004: researchers spent two years isolating the molecule that would become Gleevec and devoted another eight years to safety testing and development before they were ready to try the drug in patients. Early clinical trials showed great promise; the innovator moved quickly to expand clinical trials to include more patients; and the drug was granted "fast-track" designation to receive accelerated FDA review. And even with all this promise and focus, Gleevec still took more than 11 years to get from the laboratory through FDA approval. And of course, there are no guarantees. While investors may love the success stories like Gleevec, it is clear that market success for a particular medicine depends on many factors beyond the manufacturer's and investors' control, including for example, demand for a particular drug therapy and competition from other brand drugs. Consider these odds: ? Only one in 5,000 to 10,000 compounds eventually reach patients. Given these odds, it's easy to see why patents are a crucial factor in innovation. Patents provide the minimum degree of assurance for investors to risk the capital necessary to fund the pharmaceutical discovery process despite the uncertain chances of producing a commercially viable product. Simply put, scientific advances made in recent years would have been impossible without a system of intellectual property laws to provide the structure, stability and opportunity for recouping investment. II. Congress Has Attempted To Strike a Balance Between Policies That Foster Innovation and Those That Promote the Availability of Generic Pharmaceuticals Even as we discuss the critical role of patents in pharmaceutical innovation, it is important to recognize that pharmaceutical products effectively receive a shorter period of useful patent life than other types of products. To better understand this, first consider the basics about patents in other industries. The basic patent term in the U.S. is 20 years from the date the patent application is filed. Innovators in other industries -- who don't have to wait for regulatory approval before going to market -- can benefit from the patent as soon as it is granted. Recent statistics from the Patent and Trademark Office demonstrate that it takes about two and a half years, on average, from the date a patent application is filed until a patent is issued.8 Thus, patent holders that do not have to obtain FDA approval of their products may receive about 17.5 years of effective patent life, or time on the market before the patent expires.9 By comparison, pharmaceutical companies are required to obtain FDA approval before they can market their products. Let's say that it takes, as one peer reviewed study indicates, 14.2 years to proceed through the phases of drug development from early discovery, to pre-clinical work, to clinical trials, to FDA review, and finally, to FDA approvar.10 Even if we assume that a pharmaceutical company is in a position to file for a patent within the first few years of that process and that a patent issues about two and half years later, the additional time consumed by the FDA approval process means that the time the medicine is actually on the market before the patent expires will be less than the effective patent life of other products. Congress has taken some steps to address this dilemma. The Drug Price Competition and Patent Term Restoration Act of 1984 (better known as "the Hatch-Waxman Acf) 11 strove to balance the interests of innovative and generic companies and granted innovators products marketing exclusivity for limited periods and restored some of their effective patent time lost during the clinical research and FDA regulatory review of the product. Still, research demonstrates that the average period of effective life for new medicines, even with patent term restoration granted under the HatchNWaxmanAct, is between 11 and 12 years.12 And there are examples where the time of useful patent life is even less - for instance, Orudis?, a medicine used to treat pain, fever and inflammation, was approved by FDA with only 5 years remaining before its patent was set to expire. In short, pharmaceutical companies typically have less time than innovators in other industries under their patents to recoup their investments. It is important to remember that, while a patentee holds an exclusive right to manufacture, distribute and sell the patented invention for a period of time, patents do not provide immunity from competition. Pharmaceutical manufacturers always are free to - and often do - research and bring to market different innovative medicines to treat the same disease, and increasingly, there is strong competition between different patented products within the same therapeutic class. A recent study by the Tufts Center for the Study of Drug Development showed that the amount of time between the entry of the first and second drug in a class has fallen by about 78 percent since 1970.13 In fact, the average length of time before a first-in-class drug got its first direct competitor dropped from 8.2 years in the 1970s to 1.8 years in 1995.14 And of course, there is increasing and earlier competition among brand companies and generic companies as well. The same Hatch-Waxman Act that restores some of the patent life for innovative medicines also provides mechanisms to speed the development and approval of generic copies of those medicines. The law created the Abbreviated New Drug Application (ANDA), under which a generic product needs only to be shown to be "bioequivalent" to an innovator drug and can be approved without any additional research once the innovator's patent and exclusivity periods have expired.15 In addition, the Hatch-Waxman Act created a unique exception to patent law by allowing generic manufacturers to use innovator medicines still under patent to obtain bioequivalency data for their FDA applications (a use that otherwise was considered patent infringement).16 This allows the generic company to forego the burden and expense of performing its own studies on safety or efficacy and puts it in a position to be ready to market its copies as soon as the innovator patents expire. The generic company may even seek approval for a generic version of a drug prior to the expiration date of the innovators' patents, provided it certifies that the patents are invalid or will not be infringed by the manufacture, use, or sale of the generic drug.17 This certification, known as a Paragraph IV certification, may be filed as early as four years after FDA approval of the brand product. The Hatch-Waxman Act stimulated the development of a robust generic pharmaceutical industry in the U.S. Since the law's passage, the generic industry share of the prescription drug market has jumped from less than 20 percent to almost 60 percent today.18 Before the 1984 law, it took three to five years for a generic copy to enter the market after the expiration of an innovator's patent. Today, generic copies often come to market almost as soon as the patent on the innovator product expires.19 Prior to Hatch-Waxman, only 35 percent of top-selling innovator medicines had generic competition after their patents expired.20 Today, many more innovator medicines face such competition.21 In addition, there are increasing examples of generic competition before patent expiration. And in most cases, sales of innovator medicines drop by as much as 90 percent or more within weeks after a generic copy enters the market.22 III. Public Policy Favors Settlements of Expensive, Burdensome Patent Infringement Litigation In this climate of growing brand-to-brand and generic-to-brand competition, research-based pharmaceutical companies obviously have strong incentives to defend their patents against potential infringers. Generic companies also have strong incentives to challenge the innovators' patents, particularly because the Hatch-Waxman statutory scheme permits them to mount such challenges without first bringing their product to market. Therefore, it should come as no surprise to the Committee that patent litigation among brand and generic pharmaceutical companies is both common and costly.23 Numerous courts have recognized that "public policy wisely encourages settlements.',24 Courts and experts likewise have stated unequivocally that settlement of patent litigation can benefit consumers. As the Eleventh Circuit has stated there is "no question that settlements provide a number of private and social benefits" when compared to the costs of Iitigation.25 The Sixth Circuit has said "[t]he importance of encouraging settlement of patent-infringement litigation ... cannot be overstated...26 And leading antitrust expert Herbert Hovenkamp explains that the general principle encouraging settlements is so strong that some agreements that would be unlawful outside of the litigation context may be lawful when used to settle a bona fide patent dispute.27 It is basically a truism that patent litigation is complex, lengthy and extremely expensive for all concerned. U.S. patent litigation overall has been estimated to cost about $1 billion annually.28 Another study found that the median expense for patent litigation with more than $25 million dollars at risk is $4.5 million.29 The costs of patent litigation in the pharmaceutical industry likewise are significant. In fact, at the administrative hearing in the Schering-Plough - FTC case, one expert witness estimated that for every dollar spent on pharmaceutical research and development, about 27 cents is spent on patent Iitigation.3O And it is not uncommon for a patent dispute to last several years.31 As these figures illustrate, settlements allow both litigants and the court system to conserve resources that can then be put to more efficient use. Aside from these direct costs of patent litigation, the uncertainty surrounding an ongoing patent dispute can stall a company's business activities indefinitely. Particularly at early stages of a case, litigants face uncertainty over how the case will be resolved, because that resolution is dependent on a myriad of unknown factors, including a judge's interpretation of difficult legal questions, heretofore unknown facts uncovered during discovery, unpredictable juries, and even lawyer competence. This uncertainty can chill productive activities that are affected by a case even if they are not directly implicated by it. For example, a pharmaceutical company with even a strong patent nevertheless might face an uncertain judgment in a case brought by a generic challenger, and therefore may delay or forego innovative activity because of the prospect of an adverse judgment affecting its bottom line. Settlements create an environment of certainty, which allows parties to make business planning decisions with more efficiency and flexibility than can be achieved in the midst of an all-or-nothing legal dispute that may take years to resolve. It is therefore important that PhRMA members continue to have options to enter into procompetitive settlements, which allow them to get on with the business of developing new medicines for patients. IV. A Rule That Bans The Transfer Of Anything of Value From a Brand to A Generic in Connection with Patent Settlements Would Make Settlements Less Likely and Less Efficient and Would Threaten Both Innovation and Generic Drug Development A law that would ban patent settlements just because the brand company transfers something of value to the generic (as proposed in legislation introduced in the 109th Congress, S. 3582) would chill all patent settlements. In fact, as Judge Richard Posner has pointed out, this broad description could almost cover any settlement agreement because a generic challenger logically would only settle in exchange for something of value. And a law restricting parties' ability to settle their patent dispute would have significant adverse consequences for brand and generic companies and ultimately for patients. Fewer options for settlement would raise the cost of patent enforcement (and patent challenges) by forcing both sides to incur additional litigation costs. It could also reduce generic manufacturers' incentives to challenge patents in the first place by reducing their options in litigation against patent holders. Settlements are not easily crafted or achieved. Often - as in the context of patent infringement litigation involving pharmaceuticals - the parties have a different risk-reward calculus, a different appetite for risk, and different litigation costs. Consider the incentives of the parties in a patent dispute within the Hatch-Waxman framework. The innovator and generic are likely to face significantly different risks and rewards from patent litigation. For example, the innovator stands to lose the market exclusivity through which it recoups the hundreds of millions of dollars invested in making new products available to patients. On the other hand, the generic may risk losing comparatively little. The generic's development costs are just a fraction of the innovator's costs because the generic takes advantage of much of the innovator's development efforts. Moreover, the generic is not exposed to any infringement damages as a result of the Hatch-Waxman statutory scheme.32 The innovator and generic can also face lopsided benefits from winning. If the innovator wins, it merely maintains the status quo. If the generic wins, however, it is rewarded by profits from the sale of a new product. The parties' differing risk exposure, however, should not suggest that the innovator always has more at stake, or that the innovator is always more willing to settle. For example, the innovator may be less willing to settle precisely because of the value of the marketing exclusivity conferred by its patent. The innovator may be willing to take the risk of losing in return for a chance of a court judgment securing its entitlement to market exclusivity for the full life of its patent. On the other hand, the generic may have significant incentives to settle because it may not be able to afford the staggering costs of patent infringement litigation. The parties' risk exposure and perceptions affect their willingness to settle as well as the settlement terms each party is willing to accept. When the parties' risk exposure and perceptions differ, as they are likely to in the context of brand-generic litigation under the Hatch-Waxman framework, settlement may be very difficult to achieve.33 Patent litigation - and settlement of patent cases - also cannot be viewed in a vacuum. Companies generally, and drug companies involved in patent litigation specifically, are often interacting on multiple levels, involving separate deals and perhaps disputes. Many times, they also have assets that are not involved in the suit that are more valued by the other party. For example, one of the parties may possess technology that can be more effectively marketed by the other party. The ability to license this technology, and offer that as part of a settlement, can facilitate the parties' efforts to reach and structure a mutually acceptable - and procompetitive - settlement. This has in fact been demonstrated in the very cases that have come before the courts.34 The parties to a patent dispute are, in short, often repeat players that have interactions or potential interactions on a number of different levels. Foreclosing the ability of innovators and generics to exchange assets that mayor may not be involved in the litigation, as would be the case if there was a blanket prohibition on the exchange of anything of value, would put a straight jacket on the settlement negotiations. Not only would it make settlements less likely, but it also would make them less efficient. It would also harm consumers, since "Hatch-Waxman settlements ... which result in the patentee's purchase of a license for some of the alleged infringer's other products may benefit the public by introducing a new rival into the market, facilitating competitive production and encouraging further innovation."35 Finally, a broad ban on payments of anything of value would open any transaction between the innovator and generic up to scrutiny. It is not hard to imagine an argument that a wholly separate license deal or other business transaction was in fact part of a patent settlement and therefore should be deemed illegal. Opening up this pandora's box of litigation would be expensive and wasteful. For these reasons and others, courts and competition experts have expressed significant concerns about a rule that broadly condemns all settlements where the innovator transfers something of value to the generic. As the Eleventh Circuit stated in the Schering-Plough case; Given the costs of lawsuits to the parties, the public problems associated with overcrowded court dockets, and the correlative public and private benefits of settlements, we fear and reject a rule of law that would automatically invalidate any agreement where a patent-holding pharmaceutical manufacturer settles an infringement case by negotiating the generic's entry date, and, in an ancillary transaction, pays for other products licensed by the generic. Such a result does not represent the confluence of patent and antitrust law. The Eleventh Circuits concern that a ban on all payments from an innovator to a generic will have negative effects on settlements was echoed by the United States in its amicus curiae brief on the FTC's petition for certiorari in the Schering case. In its amicus brief, the United States stressed that lithe public policy favoring settlements, and the statutory right of patentees to exclude competition within the scope of their patents, would potentially be frustrated by a rule of law that subjected patent settlements involving reverse payments to automatic or near-automatic invalidation."3? It further recognized that the Hatch-Waxman Act creates a unique litigation dynamic that makes some settlements reasonable. Given the importance of settlement and the obstacles to reaching settlement, any limit on the ability of parties to achieve settlement must be approached with great caution. Any limit on settlement options increases the risk that the parties may not be able to reach settlement or that the settlement will be less efficient - and ultimately worse for consumers - than prohibited alternatives. Limits on the ability to settle brand-generic lawsuits also increase the uncertainty over the scope and duration of patent protection. Faced with this increased uncertainty, innovator pharmaceutical companies likely will be less willing to make the astronomical investments necessary for developing and testing novel pharmaceuticals. Innovators can only afford to make these investments because they have the opportunity to recoup them through market exclusivity guaranteed by patent protection. Innovators can therefore be expected to develop fewer new products under a regime that constrains settlement options. This effect on innovators has been recognized by the courts and has been one of the key drivers in their refusal to accept a rule that would effectively prohibit all reverse payments. As one court put it, "the caustic environment of patent litigation may actually decrease product innovation by amplifying the period of uncertainty around the drug manufacturer's ability to research, develop, and market the patented product or allegedly infringing product."38 The consequences of reduced innovation likely would in turn be felt throughout the health care system. Medicines represent just 10.5 cents of each dollar that is spent on healthcare, and only seven cents of that is attributable to brand name medicines.39 Yet evidence shows that new medicines reduce the cost of healthcare. One study found that for every dollar spent on newer medicines in place of older medicines, total healthcare spending is reduced by $6.17.40 Another found that every additional dollar spent on healthcare in the U.S. over the past 20 years has produced health gains worth $2.40 to $3.00.41 Overly broad limits on the ability to settle patent litigation may also have detrimental effects on generics. As Judge Posner recognized, limits on settlement structure, like a rule prohibiting reverse payments, "would reduce the incentive to challenge patents by reducing the challenger's settlement options should he be sued for infringement, and so might well be thought anticompetitive...42 Moreover, limits on settlement will limit a generic's ability to gain access to technology or other assets in the pioneer's possession that may improve the generic's ability to bring to market other substitutes for brand-name products. Similarly, sweeping limits on settlements will increase the possibility of a court ruling of infringement. An infringement ruling prevents a generic from making any sales to recoup its investment in developing its product. Generic manufacturers may, therefore, develop fewer generic drugs and may take longer to bring those drugs to market under a legislative regime which constrains settlement options. Finally, fewer settlements mean that litigants will spend more time and money litigating. By spending more time and money on litigation, the litigants will have to make corresponding cuts in their other expenditures, including expenditures invested in new drug development. V. A Case-By-Case Approach By Courts And Enforcement Agencies Will Allow Procompetitive Patent Settlements to Proceed and Still Deter Settlements That Harm Consumers On Balance The question then is what is the best way forward in addressing the competitive nature of brand-generic settlements in patent litigation. PhRMA respectfully submits that a legislative solution may not be necessary, and, more importantly, a broad per se ban on all settlements involving payments by the innovator to the generic is not in the best interests of patients or competition. The antitrust agencies and courts are in the best position to evaluate the facts of particular cases and determine whether particular settlements are truly anticompetitive. Questions relating to the antitrust validity of settlements that include payments from innovator to generic are currently working their way through the courts. The United States filed a brief before the Supreme Court in Schering-Plough expressing the correct view that this issue is important and there is room for debate, but that consideration by the Supreme Court was premature.43 As the brief explained, the courts' views on this issue are still emerging. As more cases work their way through the courts, a more defined body of antitrust law will emerge addressing this question and perhaps solving the debate. At the least, these opinions will further enhance understanding of this complex subject. We urge the Committee and other policymakers to continue to make policy choices that will balance patent and antitrust considerations and provide for both innovation and a strong generic industry. While the role of generics is important to our health care system, the existence of generics is dependent upon innovative pharmaceuticals being developed. Policies that incentivize research and development and allow innovator companies time to recoup their significant investment, while encouraging generic entry at the appropriate time, are essential to the lifeblood of both industries. Fundamentally, a policy that would provide for a per se ban on all settlements that contain some payment from a brand manufacturer to a generic company would put additional stress on the drug development system. It would decrease the value of patent protection generally and decrease incentives for taking the risks necessary to develop new products. One court noted, "a rule prohibiting settlements of Hatch-Waxman litigation can have grave consequences for R&D and, in turn, severe consequences for consumers ... .'144 Instead of a blanket rule banning certain types of patent settlements, enforcement agencies and courts should continue to evaluate these patent settlements on a case-by-case basis. Courts are in the best position to balance the deeply-instilled policy of settlements against a claim that a patent settlement unreasonably restrains trade and therefore harms consumers. Whether a particular patent settlement is appropriate turns on whether the settlement excludes competition beyond the scope of the patents protection. As Hewitt Pate, the former head of the Department of Justice's Antitrust Division, has recognized, "[if] a patent is valid and infringed, then any competitive entry allowed by a settlement is up to the patent holder."45 This kind of analysis can only be done on a case-by-case basis. And, of course, the enforcement agencies already have the authority and ability under current law to review and evaluate individual patent settlements. Under the Medicare Modernization Act, brand and generic companies settling patent litigation arising out of the generic company's Paragraph IV certification must file a copy of their settlement agreement or a written description of it with FTC and with the DOJ's Antitrust Division before the date when the generic product may enter the market. Thus, Congress has already given enforcement authorities the ability to review and evaluate patent settlement agreements between a brand and generic company on a case-by-case basis. Reports in the press and the FTC's own public reports indicate that the FTC maintains its interest in monitoring these agreements, and it retains the power to challenge any agreement that it deems anticompetitive. A total ban on an entire category of settlements is unnecessary - that kind of blanket rule is overbroad and would chill all settlements I even those that allow generic entry before patent expiration or contain other provisions that facilitate the availability of products to help patients live longer, healthier lives. Thank you again for the chance to speak with you today. PhRMA and its member companies believe it is crucial for this Committee and other policymakers to find public policy solutions that will strike a balance between patent and antitrust considerations and will foster innovation while still allowing for a strong generic industry. We welcome your interest in this issue, and look forward to working with members of the Committee and others in Congress as you address these and other important policy issues relating to innovation and access to medicines.
2. 35 U.S.C. ? 282. 3. See Simpson v. Union Oil Co., 377 U.S. 13, 24 (1964) ("[T]he patent laws ?.. are in pari materia 4. Atari Games Corp. v. Nintendo, Inc., 897 F.2d 1572, 1576 {Fed. Cir. 1990}. 5. See, e.g., Ethyl Gasoline Corp. v. United States, 309 U.S. 436, 456 (1940). 6. Monsanto v. McFarland, 302 F.3d 1291, 1298 (Fed. Cir. 2002). 7. See, e.g., JA DiMasi, "New Drug Development in the United States from 1963 to 1999", 8. See The United States Patent and Trademark Office, "Frequently Asked Questions About 9. See U.S. Patent And Trademark Office, Performance and AccountabilitY Report Fiscal Year 10. J.A. DiMasi, "New Drug Development in the United States from 1963 to 1999," Clinical 11. Pub. L. No. 98-417, 98 Stat. 1585 (1984), 21 U,S.C. 355. 35 U.S.C. 156, and 35 U.S.C. 271. 12. H.G. Grabowski and J. Vernon, "Longer Patents for Increased Generic Competition in the U.S. 13. DiMasi JA, Paquette C. The Economics of Follow-On Drug Research and Development: 14. Op. Cit. 15. 21 U.S.C.3550). 16. 35 U.S.C. 271 (e)(1). 17. 21 U.S.C. ? 3550){2){A}(vii}(IV). 18. Generic Pharmaceutical Association, "Statistics" (accessed January 15, 2007) 19. Congressional Budget Office. How Increased Competition frOm Generic Drugs Has Affect9d 20. 1998 cbo Report (citing Henry Grabowski and John Vernon, Longer Patents for Lower 21. 1998 cbo Report. 22. Javed Sayed, "Indian firms' U.S. generic market scope looks bleak," The Economic Times: 23. The Paragraph Four Report, Frequently Asked Questions, accessed on January 15, 2007 24. McDermott, Inc. v. AmClyde, 511 U.S. 202, 215 (1994). 25. Schering-Plough Corp. v. Federal Trade Commission, 402 F.3d 1056,1072 (11th Cir. 2005). 26. Schlegal Mfg. Co. v. V.S.M. Corp.? 525 F.2d 775, 783 (6th Cir. 1975) 27. Settlements Resolving Intellectual Property Disputes, 12 Herbert Hovenkamp, Antitrust Law ~ 28. Steven C. Carlson, Patent Pools and the Antitrust Dilemma, 16 Yale J. Reg. 359. 380 (1999). 29. Am. Intellectual Prop. Law Ass'n, Report of the Economic Survey 2005, at 22 (2005). 30. Opening Brief of Schering-Plough Corp., 2004 WL 3557974, at 48 (11th Cir. June 1, 2004). 31. Federal Trade Commission, "Generic Drug Entry Prior to Patent Expiration," July 2002, at Hi 32. Schering-Pfough, 402 F.3d at 1074 (explaining that "the Hatch-Waxman Amendments grant 33. Schering-Plough, 402 F.3d at 1073 C'Schering presented experts Who testified to the litigation 34. See, e.g., Schering-Plough, 402 F.3d at 1059-61 (discussing settlements in which assets were 35. Schering-Plough, 402 F.3d at 1075. 36. Schering-Plough, 402 F.3d at 1076. 37. Brief for the United States as Amicus Curiae, FTC v. Schering-Plough Corp.? No. 05~273 (filed 38. Schering-Plough, 402 F.3d at 1075. 39. http://www.innovation.org/index.cfmllmpactoflnnovation/Controlling_Healthcare _Costs 40. F. Lichtenberg, Benefits and Costs of Newer Drugs: An Update. National Bureau of Economic 41. MEDTAP Int'l, Inc.? The Value of Investment in Health Care: Better Care, Better Lives 42. Asahi Glass Co. v. Pentech Pharm., 289 F.Supp.2d 986, 994 (N.D. III. 2003) (Posner, J., sitting 43. Brief for the United States as Amicus Curiae, FTC v. Schering~Plough Corp., No. 05-273 (filed 44. In re Ciprofloxacin Hydrochloride Antitrust Litigation, 261 F. SUppa 2d at 256. 45. R. Hewitt Pate, Assistant Attorney General, Antitrust Division, Address to the American |


text:
featured in Modern & Unique
featured in Bridal Shower
featured in Golf Event
featured in Gender Reveal
featured in Kids Birthday
featured in Grad Announcements
featured in Easter
featured in Personalized Stationery
Share your gratitude with an event for the dedicated members of your community! These Volunteer & Customer Appreciation event invitations are the perfect start to an event to honor those who give of their time and resources to help others and to those who's patronage helps your business to thrive. Shop Volunteer & Customer Appreciation event invitations and order today.
Oops! You've narrowed your search a little too much! Clear your search and try again.
One Moment Please
Back to Top

subset: commoncrawl


text:
The American Red Cross has opened a shelter in Woodward to help travelers stranded by Monday's deadly blizzard.
The winter storm dumped more than a foot of snow across Woodward, shutting down highways and leaving some drivers with no place to go.
Woodward Emergency Manger Matt Lehenbauer asked the Red Cross to provide a place for stranded travelers. The Red Cross opened a shelter at the Pioneer Room on 9th Street. The shelter will remain open as long as it is needed.
Schools, businesses and roads remain closed in Woodward as the city tries to recover from the powerful winter storm.
Check Oklahoma road conditions online
One person died Monday when the heavy snow collapsed part of a roof at a Woodward home.
2/25/2013 Related Story: 1 Dead In Woodward When Snow Collapses Home's Roof
Know when severe weather moves into Oklahoma! Download the I-News Desktop Radar.
Get breaking news, weather, sports & video directly on your iPhone.
Get breaking news, headlines, weather alerts & more on your cell phone.
Use our free classifieds to find the things you need or sell your items.
Need to know what's on TV? Check out our television schedule.


text:
Cleaning Bucket Assembly & Shipping Instructions
These supplies enable people to begin the overwhelming job of cleaning up after a flood or hurricane.
Cleaning Bucket PDF (2pp, 87K)
Cleaning Bucket Kit Items
Value: $55 per bucket.
- 5-gallon bucket with resealable lid
Buckets from fast food restaurants or bakeries can be used if washed and cleaned.
Do not use buckets that have stored chemicals such as paint or pool cleaner.
Advertisements on the outside are acceptable
- liquid laundry detergent
(two 25 oz. or one 50 oz. bottles only)
- liquid household cleaner
12-16 oz. liquid cleaner that can be mixed with water
no spray cleaners
- dish soap
16-28 oz. bottle, any brand
- 1 can air freshner
aerosol or pump
- 1 insect repellant spray
6 - 14 oz. aerosol spay pump with protective cover
- 1 handheld scrub brush
plastic or wooden handle
no toilet-bowl brushes
no kitchen or dish brushes
- 18 cleaning wipes
handi wipes or reusable wipes
no terry cleaning towels
remove from packaging
- 7 sponges
no cellulose sponges due to mold issue
- 5 scouring pads
remove from wrapper
no Brillo, SOS pads or any kind that will rust
- 50 clothespins
remove from packaging
- clothesline
two 50ft. or one 100ft.
cotton or plastic
- 24-roll heavy duty trash bags
30 - 45 gallon size
remove from the box
- 5 dust masks
- 2 pair disposable kitchen gloves
rubber or latex
remove from packaging
- 1 pair work gloves
leather palm necessary
Assembling Directions
Place all liquid items in the bucket first. Place remaining items in the bucket fitting them around and between the liquid items. Sponges, scouring pads, clothespins and trash bags can be separated in order to fit all of the items in the bucket. Ensure the lid is closed securely.
Important Notes
‐All items must be new except for the actual bucket and lid.
‐All cleaning agents must be liquid and in plastic containers. No powders please.
‐If you cannot find the requested size of a liquid item, use a smaller size. Including larger sizes of any item will prevent the lid from sealing.
‐UPS, FED EX and the US Postal Service will not ship buckets containing bleach. In such case, you may leave the bleach out of the bucket.
‐If all of the items on the list are not included, please put a label on the bucket indicating what has been omitted.
‐Cleaning buckets are only used within the United States. They are not opened to verify the contents unless there is indication some items have been omitted.
Packing Kits
- Box Weight. Each packed box cannot exceed 66 pounds.
Shipping Kits
- Complete 2 packing lists-one for your records and one to put on the shipping box.
- Paste the shipping label / packing list on the outside of each box you send. The shipping list helps the depot to quickly process kits.
- Processing & Shipping Costs: Please enclose an envelope containing at least $1 for each kit you send. This donation enables kits to be sent without delay to areas in need. For Cleaning Buckets: $1.50.


text:
Forte Lighting 10018-01 Energy Efficient Brass Dark Sky Craftsman / Mission Outdoor Wall Sconce
Technical Specs
Bulb Included | Yes |
Bulb Type | Compact Fluorescent |
Dark Sky | Yes |
Extension | 6.25 |
Height | 7.25 |
Installation Available | Yes |
Light Direction | Ambient Lighting |
Material | Brass |
Number of Bulbs | 1 |
Suggested Room Fit | Outdoor |
Theme | Craftsman |
UL Listed | Yes |
UL Rating | Wet Location |
Wattage | 18 |
Watts Per Bulb | 18 |
Width | 6.25 |
Configure your Energy Efficient Brass Dark Sky Craftsman / Mission Outdoor Wall Sconce
Get It Installed more info ▼
When you order installation services from Installations Direct, a certified service provider in your community will contact you within 24 hours to make an appointment for your installation.
The service provider will install the new fixture and haul away the old fixture and any excess installation-related materials.
Finish configuring above to see price
Please finish configuring above
- Single Light Outdoor Wall Sconce
- Energy Efficient Fixture
- Dark Sky Compatible (Specify Finish with Dark Sky Compliant Fixtures)
- Features Honey Glass Panels and Brass Construction
- Extends: 7"
- 1-18w 4-Pin Spiral Fluorescent Bulb (Included)
- Replacement Bulb: 80001
Additional Forte Lighting Links
- View Manufacturer Warranty
- Shop All Forte Lighting Products
- Shop All Forte Lighting Energy Efficient Sconces Collection Products
Our SKU: 10018-01
This product is listed under the following manufacturer number(s):
- 10018-01-38*
Copper - 10018-01-38DS*
Copper (Dark Sky) - 10018-01-14
Royal Bronze - 10018-01-14DS*
Royal Bronze (Dark Sky)
*Denotes a finish or option that has been discontinued
5 Questions from the Community
What kind of mount is used? Is the bottom open? Is it suitable for mounting on a four inch wide post?
A. The Forte Lighting 10018-01 is an wall sconce, so this won't fit on a 4" wide post. Unfortunately I don't see a post light in the same collection, so if you look under post lights and narrow the results by mission style you should be able to find a similar post light.
What color is honey glass?
What is the size of the back plate, will it fit a 51/4" box?
What kind of metal is this light made of?
what are the dimensions of this product?
Forte Lighting Energy Efficient Sconces Collection
Other Products In The Forte Lighting Energy Efficient Sconces Collection
Forte Lighting 10008-01
Energy Efficient Traditional / Classic Outdoor Wall Sconce
$25.30$23.00(6) -
Forte Lighting 50012-01
Energy Efficient Up Lighting Wall Sconce
$80.59$76.86(4) -
Forte Lighting 55000-01
Functional Energy Efficient Wall Washer Sconce
$85.14$81.00 -
Forte Lighting 17020-01
Energy Efficient Craftsman / Mission Outdoor Wall Sconce
$150.48$142.20(3) -
Forte Lighting 10005-01
Energy Efficient Traditional / Classic Outdoor Wall Sconce
Warranty Info
Forte Lighting, Inc. warrants its products against structural defects only, for one (1) year of shipment. Finish of our product is warranted for six (6) months after date of shipment. Products that are stored or used in extremely damp or salty air locations and / or conditions, which includes, but not limited to, intense sunlight, high winds, or acid rain, where product tends to tarnish easily, are warranted three (3) months from date of shipment. Forte Lighting, Inc. will replace, at our discretion, products that fail to operate structurally, within the warranty does not cover products that were improperly installed or those in which parts have been tampered with or changed. The compliance of our product to project specification and approval for their use is not warranted by our company. Product sold as "Discontinued" or "Close-Out", is not warranted by our company and is not returnable.
Forte Lighting, Inc. will not be responsible or liable to buyer, its' agents employees, or any third party for cost incurred in the removal or reinstallation of any incidental damages resulting in loss of use, loss of revenue. Loss or profit, arising out of, or in connection with natural disaster, catastrophe, fault or negligence of the user or any third party, including without limitation, shipping and / or damage.
Except as stated herein, there are no warranties expressed or implied. Warranty period begins on date of shipment from Forte Lighting, Inc.


text:
Five Across The Eyes Reviews
Greg Swinson and Ryan Thiessen team together to deliver an impressive debut film that, even with all of it's problems, is still going to blow some of your minds.
Read Bloody Disgusting's Full Review
"Unwatchable" is not a term I throw around often but Five Across the Eyes is a project that warrants it. Notice I did not say film, since this is more akin to a 90-minute YouTube video. Trying to make a MORE
I don't know how many indie films you may have watched in your time as a horror fan, but there's a moment, usually in the first ten minutes, when you know if what you're about to spend the next 80 MORE
As a serious horror fan, you've probably found yourself digging through more than your share of micro-budget "home-made" movies. I'm not talking independent in the normal sense; I mean a movie MORE


text:
The holidays will be here before you know it ... and it's not too early to start planning for gifts and cards. The Fredonia Opera House has partnered with STPhotography, of Forestville, on a special fund-raiser for the Opera House. On Sat., Nov. 12, the two organizations will offer holiday photo portrait sessions onstage at the Opera House.
"There are several beautiful settings available," says Opera House Executive Director Rick Davis, "so you can have your child's or pet's or family's photo or your own photo taken with Santa or simply in a holiday setting. STPhotography's work is stunning, so regardless of the setting you choose, you'll be thrilled with the result. "
Davis notes that this is the third year for the fund-raiser and that a special offer is being extended to supporters who participated last year. "For those returning participants from last year, if you bring a new participant who signs up for a portrait sitting this year, your own order will be doubled free of charge."
Article Photos
Four special portrait packages will be offered with a portion of the fee for each package to benefit the Opera House:
Basic Package includes photo session and two 5x7 portraits $40 (entire fee donated to Opera House)
Upgraded Package includes photo session, two 5x7 portraits and one 8x10 portrait $75 ($40 donated to Opera House)
Extended Package includes photo session, two 5x7 portraits, one 8x10 portrait and 14 wallets $100 ($40 donated to Opera House)
Greeting Card Package includes photo session and 24 multiple-image greeting cards w/envelopes and customized text $160 ($40 donated to Opera House)
Additional portrait prints also are available for purchase with a package. To make an appointment for a photo session, contact the Opera House at (716) 679-0891.
The 1891 Fredonia Opera House is a member-supported, not-for-profit organization located in Village Hall in downtown Fredonia. A complete schedule of Opera House events is available at www.fredopera.org.


text:
Origin and popularity
Oona is not a popular first name. It is more often used as a girl (female) name.
People having the name Oona are in general originating from Ireland, United Kingdom.
Name meaning of Oona
- One
Numerology Interpretation
- Name Number: 9
- Interpretation: Divine, God, Goodness, Truth, Unconditional love, Gift, Free will, Ideal, Whole, Endless
Name compatibility
Popularity of the given name
The name Oona is ranked on the 21,437ᵗʰ position of the most used names. It means that this name is rarely used.
We estimate that there are at least 4200 persons in the world having this name which is around 0.001% of the population.
The graph below represents the number of people which were given this name for each year since 1900 in the U.S.A.:
The name Oona has four characters. It means that it is relatively short-length, compared to the other names in our database.
Name Day Calendar
Want to celebrate the name day of Oona? Check our Name Day Calendar.
That's all we've got for now!
We always try the deliver a high-quality service to our customers. If you consider the information on this page is incomplete or incorrect, please contact us by using our Web form. Please read also our Disclaimer and No Guarantee Of Validity notices.
Thank you!


text:
Weaver set for first Opening Day nod
Young hurler completely healthy, stepping up in time of need
It isn't exactly the way Jered Weaver would have scripted it, but drawing a starting assignment on Opening Day in the Major Leagues is always a distinction of merit. And it belongs to Weaver in Minnesota's Metrodome for the reigning American League champion Angels.
For Weaver, embarking on his third season with the Angels at 25, it comes with Kelvim Escobar dealing with what he fears could be career-threatening injury (labrum tear in right shoulder) and John Lackey (strained right triceps) sidelined and not expected back until May.
"It's obviously an honor," Weaver was saying, "but I know Eskie or John would be there if they weren't hurt. It kind of takes away from it a little."
As the twin aces, Lackey and Escobar, were going through their rehabs, Weaver clearly emerged as the club's lead pitcher with a dominant spring.
"With those guys on the DL," Weaver said, "we're just trying to pick them up until they get back."
In full command of all of his pitches this spring, the 6-foot-7 right-hander has recaptured the form that earned him wins in his first nine Major League decisions in 2006, matching the Yankees' Whitey Ford, who did it in 1950.
Weaver's 2007 season began with biceps tendinitis, and he never regained the confidence he brought into his rookie season. His 13-7 record and 3.91 ERA were respectable, but that wasn't what he had in mind for himself.
"You never like to have to compensate for being hurt," Weaver said. "I'm not saying I was completely hurt, but there was something happening where I couldn't throw the way I wanted to throw. I had to change some things just to get through it.
"I'm not taking as much time off in the winter now. Coming here healthy and getting back to where I wanted to be is a relief. It's nice to be comfortable, to go out there without worrying about being right."
Weaver's rediscovered confidence has been evident in his ability to put away hitters when situations demand it.
"It's a presence," Weaver said, "being out there knowing you can compete at your highest level."
After loading the bases against the Rangers in a Cactus League game this spring, Weaver set down No. 3 and No. 4 hitters Josh Hamilton and Hank Blalock on crackling fastballs and cruised through seven efficient innings.
"You get guys on base, that's when you kind of get locked in," Weaver said. "With nobody on, you're just concentrating on throwing strikes. Bases loaded, second and third, it's like situations during the season. You concentrate like in the season.
"I don't like to focus too much on results in Spring Training, but when you get the bases loaded -- whether it's here or in a Little League game -- you want to get out of it and not give up any runs. So I felt pretty good about that."
Manager Mike Scioscia is enthused about Weaver and how he has emerged this spring in a time of need.
"Weav looks great," Scioscia said. "He put in the work, and he is showing what he can do. This guy's a tremendous talent."
Lyle Spencer is a reporter for MLB.com. This story was not subject to the approval of Major League Baseball or its clubs.


text:
A new generation of artists have begun showing face in the corners of Los Angeles and across the globe. Directly influenced by acts closely associated with BTS, Henry Laufer, known as Shlohmo, is one of the names that's been propelled as a captain to this new squad. Balancing between slow motion ambiance and aggressive bass hits, Laufer's productions have a lot more heart compared to most up and comers. When you speak with Laufer, you can hear his enthusiasm, hunger and respect for names he's now being mentioned with side by side. That same attitude is directly projected in his tracks. A young man eagerly wanting to share his music with the world and with the people who've shaped his production. But get it straight, he's not an imitation or trying to catch onto any particular scene. He's just doing what he knows best. That's setting up himself up to crash into the electronic world and grab it by the neck. His latest EP, Camping, is set for digital release June 15th on Friends Of Friends. The EP will also include remixes by Baths, Asura, and Shigeto. For more on Shlohmo, visit: www.wediditcollective.com www.twitter.com/shlohmo www.myspace.com/shlomoshun
Original Air Date: May 25, 2010 Running Time: 37 minutes TRACK LIST: Comfort Fit - Sky Raper (Shlohmo Remix) Jonwayne - Face Bomb Joseph - Untitled #3 yuk. - Adept-ation s.maharba - She Lee Moses - Bad Girl Jeremiah Jae - Vertical Pupils Gonjasufi - Change (Shlohmo Remix) Infinitirock - Not A Peacock Groundislava - Culminate Baths - Lovely Bloodflow Oh No Ono - Swim (Shlohmo Remix) Cedric Brooks - Ethiopia Express Rising - Ice Stopped


text:
3 hrs ago | FoodNavigator
ADM to go into commercial scale production of 'invisible' soy protein CLARISOY
Archer Daniels Midland Company plans to move into full-commercial scale production of CLARISOY - the 'invisible' soy protein developed by plant protein pioneer Burcon.
Trending on the Topix Network
8 hrs ago | The Miami Herald
The stock-for-stock transaction announced Monday creates a global banana and fresh produce company with $4.6 billion in annual revenues.
12 hrs ago | The Beaumont Enterprise
Stocks end slightly lower on China growth worries
Stocks drifted to a slightly lower finish Monday as investors sifted through a blend of discouraging economic data from China and Japan as well as ongoing uncertainty over Russia's incursion into Ukraine.
12 hrs ago | The Island Packet
Stocks end slightly lower on China growth worries
In this Friday, Feb. 21, 2014, file photo, trader Gregory Rowe, center, works at the post of specialist Joseph Mastrolia, left, on the floor of the New York Stock Exchange.
16 hrs ago | AmericanBankingNews.com
Archer Daniels Midland Receives Consensus Rating of "Buy" from Analysts
Shares of Archer Daniels Midland have earned an average recommendation of "Buy" from the fifteen brokerages that are presently covering the company, Stock Ratings Network reports .
16 hrs ago | Bakery & Snacks
US senators demand Kellogg act fast to end Memphis lockout
The senators are not the only people that have written to Kellogg CEO John A. Bryant calling for an end to the Memphis lockout.
18 hrs ago | Value Line
Stock Market Today: March 10, 2014
Stocks to Watch from The Survey - The saying that "there's always money in the banana stand" is ringing true this morning, as shares of Chiquita Brands are moving sharply higher ahead of the bell, after the company, which sources and distributes bananas and other fresh produce, agreed to merge with industry peer Fyffes in an all-stock transaction ... (more)
22 hrs ago | KTVN Reno
Chiquita combines with Fyffes to be top banana
Officials say a powerful magnitude 6.9 earthquake struck Sunday night off the coast of Northern California, but there were no early signs of a tsunami.
Yesterday | Sys-Con Media
Chiquita Brands International, Inc. And Fyffes Plc To Combine To...
The agreement creates a global banana and other fresh produce company with approximately Chiquita is a leading international marketer and distributor of nutritious and high-quality fresh food products, including bananas, packaged salads and healthy snacks.
Agriculture - the environment's problem or answer?
Is the agriculture industry the environment's problem or part of the answer, that was the question asked by Prysor Williams, Bangor University's lecturer in Environmental Management, to those present at the recent Ceredigion NFU Cymru Annual Conference.
In Person: Bellingham inventor sticks with it and succeeds
Mark King, in his small manufacturing studio in Bellingham, says the idea for his organoleptic analyzer, a device that measures the texture of granola bars, came to him when he was a 21-year-old college dropout.
Make reservation for murder mystery dinner
Willamette Valley Vineyards is taking reservations for its Murder Mystery Wine Dinner on March 23. Guests will try to piece together clues to solve a mystery in the "whodunit" event, interacting with the winery staff and characters.
Social Pow Wow is a celebration of tribal heritage
Men and women in traditional Native American regalia danced, sang and drummed in the 12th annual Social Pow Wow at Willamette University Saturday.
Chrys Peterson, left, and Jerry Anderson announce the arrivals as they enter the Oscar Party in the Center for Performing Arts at Owens Community College.
Grain handler GrainCorp reveals downsides of failed takeover
Australia's biggest grain handler GrainCorp is warning of tough times ahead in the wake of the failed US takeover of the company.
Petri's factory purchased for storage
Petri's produced cookies in the village of Silver Creek for decades before the company was sold to Ralcorp Holdings in 2012 and Ralcorp was purchased by ConAgra Foods in 2013.
Chamber of Commerce honors Salem leaders in First Citizen banquet
For 64 years, the Salem Area Chamber of Commerce has been honoring members of the community for their contributions and accomplishments with the Annual First Citizen Awards Banquet.
Letter: Kellogg did right on palm oil
The company now has a written policy to use palm oil that has been obtained through sustainable sources.
CHS Board Member Named Coop Director of the Year
Washington, DC-The National Council of Farmer Cooperatives has awarded its prestigious Director of the Year award to Curt Eischens, a farmer director of CHS Inc. , the nation's leading farmer-owned cooperative and a global energy, grains and foods company.
Councilmember Guzman proposes streamlining agricultural regulations
Councilmember Don S. Guzman has introduced a resolution urging the administration to adopt a unified definition of "agriculture" and a single process to verify a property's agricultural use, he announced today.


text:
Over the years, my taste in food has changed, as have my recipes. This blog will chronicle the changes I continue to make, as I face challenges in healthier eating and in new methods of cooking.
These look delicious.I haven't tried sweet potato hash browns yet, but I know I'll love them!
Your dish looks great with its sunny side up eggs. The sauce and asparagus are definitely optional.
Glad you liked it. I loved the crispy pancake with the soft egg.
CONGRATULATIONS!!! Your recipe is being featured on Today's Menu and Party Round Up from Cast Party Wednesday #35! http://www.ladybehindthecurtain.com/?p=27243Please come by and grab a "featured" button! Thank you for sharing your recipe with us! ---Sheryl---
Thanks for visiting and commenting.


text:
Serial on Android using the audio port
From RobotsEverywhereWiki
The Android platform is extremely powerful -- we've been running robots and logging systems based on it for over a year now, so we should know!
While our software and source code is available on this very wiki, we'd like to offer to the community a code snippet and a schematic that can be used to let your Android phone control any microcontroller (and from there you can move servos, motors, or whatever else) without the need to root the phone. You get 24000BPS (that's 24 thousand, not 24 hundred), which is decent (if your microcontroller or device can only do standard baud rates, you may be limited to 19200bps or 9600BPS) and since the headphones output is stereo on most phones, you actually get two serial ports! This is only for transmission right now, however. The inspiration is of course Flake Labs ( Fun, Learning, and Killer Electronics. www.flakelabs.com ) although we've moved all the logic to software in order to make the hardware as simple as possible.
Source(s): Android solutions
The hardware to use this is very simple: you will get a nice TTL signal from this. If you invert it, you can talk to a RS232 serial port directly.... happily the LM324 has four op-amps on it, so you can use the other two as inverters if you feel like it.
The "audio in" just goes back to your phone jack, with ground in the middle.
You will want to adjust the potentiometer depending on what phone and microcontroller you're using, especially at higher baud rates: in general, it should be barely above zero volts -- some phones give a bit of a bias to their headphone outputs, so make sure to stay above that.
The software can be downloaded on the Android Market by searching for re.serialout ; email me for source code at mkb(at)libero.it or download it at http://robots-everywhere.com/re_site/audioserial/
We recommend using the Picaxe microcontroller as a slave device, as it is very cheap, easy to program (no programmer required, just two resistors and a serial cable) and very tough electrically.
Don't forget that [| I sell a kit!]


text:
Cheaper computers? just bring them on. |
I'm liking the price |
Selling a Mac Book Air for $799 is a great strategy for Apple. There are many people especially with what I refer to as Apple Fever going around so quickly. I also thing that it is something they have to do to remain competitive with their own tablets and the ultrabook market considering that Intel wants all Ultrabooks to be below $1000 dollars. |
Hmmm really don't see much wiggle room spec wise that's left to Apple that would allow them to lower the price. Maybe use an i3 proc? Surely they won't use a smaller screen, and a smaller capacity hdd wouldn't make sense either. They may just have to face reality and lower their prices period. |
Oh no...steve jobs must be rolling over in his grave...Compete with price?!?! NEVAR! |
This is the kind of competition that benefits consumers, loving the price drops. |


text:
Keeping your bedroom cool during the summerJun 20 2011 Keeping your bedroom cool during the summer. One trick to cool off your bedroom is to use a dehumidifier - this will remove much of the sticky heat that is in your room and effectively cool it off during the day. There are a number of window treatments available that will reduce heat in your bedroom, but will also offer privacy and reduced air leakage during the summer. Bamboo woven wood shades are an excellent choice that will go with any interior design, and they can be fitted with privacy liners to keep prying eyes away. Honeycomb cellular shades are available in single- or dual-cell blackout varieties that will control air leakage and help to cool down your bedroom. By ordering blinds online, you can have these fashionable window treatments custom-made to fit any space. Related Products
Related Articles | (888) 633-7840 M-F 6am to 5pm Sat 6am to 3pm PST | |||||||||
Copyright © 2013 Blinds Chalet. All Rights Reserved. |


text:
Matthew Harwood is captain of the track and cross country teams at Episcopal School of Jacksonville. Matthew is in the National Honor Society, the Cum Laude Society and the Episcopal School Honor Council. He is an Eagle Scout and has volunteered with L'Arche Harbor House, the MS 150, and the Donna Deegan Marathon Expo. Matthew currently has a 4.2 GPA.
Watch his interview with sports director Sam Kouvaris
The views expressed are not those of this company or its affiliated companies. Please note by clicking on "Post" you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms.


text:
Every Monday in the Merrie England Bar at 8pm
Music - Song - Dance - Cabaret
Fantastique! returns on Mondays with a new show for 2012
2011 saw the beginning of a new family-friendly evening show in the Merrie England - Fantastique! It was so popular that we are proud to announce its return this summer.
Sara Cheston will amaze you with her songs from the shows, jazz numbers and sultry soul numbers and Ronnie Lee will astound you with his renditions of some of the classic swing and blues songs as well as some of the greatest pop songs from every era.
Fantastique! - it is what it says in the title - a fantastic show to entertain.
Entrance: FREE


text:
Residence Nuova Villa
Situated in a peaceful and sunny position at about 1 kilometre from the centre of the town of Livigno, the Nuova Villa Residence self-catering accommodation is an ideal departure point for walks and excursions in the summer and for ski-lovers in the winter.
Furnished in typical mountain style, each one-room apartment consists of kitchenette and living room with sleeping facilities (all in a single room) and a small bathroom in plexi-glass with shower, TV and safe.
Via Saroch, 782/c
23030 - Livigno (SO)
Tel.: (+39) 0342 990100 - Fax: (+39) 0342 990300
Tel.: (+39) 0342 990100 - Fax: (+39) 0342 990300


text:
Pleat Pocket Jacket
For those not-too-cold days when you still need something extra, this is the perfect topper for skinnies and a printed tee. Pleated detail on pockets. Functional button tab on right and left of back hem. Imported.
- 2 front chest snap-flap pockets
- Three-quarter-length sleeves; shirt collar
- Button-front closure; functional buttons on cuffs
- 98% cotton/2% spandex
- Machine Wash
- sku #:
Available Colors
Qty | size chart |
Complete the Look
Pleat Pocket Jacket
Navy Blue Jean Jacket
I LOVEEEEEE My Navy Blue Jacket, and DRESSBARN is the ONLY Clothing store that can dress ME.
I reccommend it to ALL.
March 3, 2014
Very nice jacket!
Love the jacket have been looking for one in navy. The shoulders and arms are cut too small. Sorry to say I will be returning it.
January 30, 2014
Cotton Jean Jacket
I love this little summer jean jacket. I bought 3 of them! (one in White, one in Navy Blue, and one in Black) It fits absolutely perfect and has a little bit of stretch to it also. to add comfort. I paired my jackets with the new Dress barn 3/4 sleeve solid Scoop neck tees and a statement necklace. The white tee goes well with the 3 row beaded necklace in geranium under the navy blue jacket with a pair of skinny jeans. And the geranium tee goes well with the white jacket and a black statement necklace. I definitely recommend these summer jackets. You will not be disappointed.
January 29, 2014
1-3 of 3


text:
Homework Help
Better Students Ask More Questions.
What/who were the Free French Forces during WWII?
Topic: World War II
What/who were the Free French Forces during WWII?
1 Answer | add yours
In World War II, the Free French were a group of French soldiers who were not affiliated with the Vichy government of France.
Early in WWII, France was defeated by Germany. Part of France was occupied by Germany. Another part remained under nominal French control. It was known as Vichy France for the city where its capital was. Vichy France was a German puppet state.
The Free French Forces were largely drawn from the French empire. Some were ethnic French who lived in the empire while others were natives of the countries of the empire. The leader of the Free French was Charles de Gaulle.
Posted by pohnpei397 on September 13, 2012 at 1:04 PM (Answer #1)
Related Questions
See all »Join to answer this question
Join a community of thousands of dedicated teachers and students.


text:
promotional discount applied. Cart total will reflect savings.
Buy 2 or more, each at $53.99 Buy 3 or more, each at $52.79
Quantity discount will reflect in cart.
This product may only be purchased with the approval of a veterinarian and may require verification. We will collect any necessary information at checkout and verify a prescription if required.
Sometimes, manufacturers require that products be advertised only at their suggested prices. When we choose to sell these items for less, we display the sale price only in the cart. To see the price, click Add to Cart.
One-time delivery
Save 10% with Auto Ship (Details) Deliver Every: 2 Weeks 3 Weeks 4 Weeks 5 Weeks 6 Weeks 7 Weeks 8 Weeks 1 Month 2 Months 3 Months 6 Months
Wellness Complete Large Breed Dry Dog Food
Starting from: $70.99
Holistic Select Puppy Canned Dog Food 12 Pack
Now: $34.99
Product Summary:
The classic P-Nuttier® bone-shaped biscutis are oven-baked with a taste of Peanut Butter and Molasses.
OMH Extra Tasty P Nuttier Dog Treat
Starting from: $59.99
Nylabone Dura Chew Ring Dog Toy
Now: $6.69
OMH Gourmet Bitz Assorted Dog Treat
Now: $59.99
KONG TRAXX Power Chewer Dog Toy
Starting at: $5.99
Hedgehog Dog Toy
Starting from: $3.59
Beefeaters Rawhide Dog Treat Stix
Starting from: $9.49
Beefeaters Wrapped Biscuits Dog Treat
Starting from: $25.99
Nature's One Wrapped Sweet Potato
Starting from: $21.99
Greenies Dog Dental Chew Treats Large
Starting from: $32.99
Air Kong X-Small Squeaker Tennis Ball
Now: $2.55
Nylabone DuraChew Ring Bone Dog Chew
Starting from: $4.20
Select Grille Knotted Rawhide Bone Kennel Pack
Starting at: $39.99
OMH Gourmet Mini Friends Dog Treat
Outward Hound Treat N Ball Bag
Starting at: $4.29
Indoor/Outdoor Faux Gusset Bed
Starting at: $74.99
Greenies Dog Pill Pocket for Capsule Peanut Butter
Now: $9.49
SPOT Dura-Fused Leather Squirrel Dog Toy
Now: $4.10
SPOT Dura-Fused Leather Raccoon Dog Toy
Product Reviews by Customers
This item is not eligible for Canadian shipping.
Some items everyday price is so low we can't discount or we have marked down the item to a final sale price. These select items will not be included in your order total when determining if your order qualifies for a promotional event.


text:
Avignon hotel reviews: 1 star hotel
2 cheap hotels in Avignon reviewed by EuroCheapo (See more hotels in Avignon by doing a CheapoSearch)
Sort By: Name Price User rating Neighborhood Most viewed
1Hotel Splendid
starAddress 17, Rue Agricol Perdiguier (Historical Center)
The one-star Hotel Splendid, located in the southern part of Avignon's center, offers 17 rooms with the basics.
2Hotel Mignon
starAddress 12, Rue Joseph Vernet (Historical Center)
The one-star Mignon, located in Avignon's historic city center just a few blocks east of the Rhone river, offers 16 air-conditioned rooms.
Check Rates for Checking Rates for No availability
xNote: This hotel does not offer online booking through our reservation partners. To see all available hotels in , please search below.


text:
Welcome, skip to the content.
Official site for Melbourne, Victoria, Australia
Have a quick glimpse and see Port Melbourne as a sunny bayside suburb with gleaming modern architecture; look closer and find restored workers cottages and grand old pubs pubs paying homage to the bean and barley in typical Melbourne style.
Beacon Cove and Station Pier Don your designer gear and pound the palm-lined path that hugs the Port Melbourne foreshore. Deviate past architect-designed houses and the high-rise apartment blocks overlooking Port Phillip Bay. Catch your breath in Beach Street's cafes, dress up for beachfront beverages, or dip your toes in the water.
Plant yourself at 3 Station Pier or Waterfront and people-watch as the Spirit of Tasmania ferry arrives, and the international cruise ships dock.
Back in Bay Street Step back from the beach to Bay Street. Scout quality coffees at Balderdash and My Sister Says and find best French provisions at Noisette. Shop up a storm at Bay Street's swanky boutiques and absorb a spot of culture at MARS Gallery. The Graham, The Local and the Railway Club Hotel will set you up with frothy beers (boutique, naturally) and top-notch pub grub, while Rose Bar & Diner and Dalmatino provide alternative dining options.
You need to retreat from the waterfront to find the suburb's best coffee, with Salford Lads Club and Station Street Trading Co. both worth a detour.
How to get there By tram: Number 109 (to Port Melbourne) from Collins Street (about 20 minutes).
By bus: Number 238 from the corner of Collins and Market streets to Bay Street to (about 25 minutes).
Port Art is a contemporary art facility, stocking art by mid-career artists whose works fit at varying levels into the highly sought after affordable...
Read more | Show on map
Auscarts is a state of the art indoor karting venue and entertainment complex just five minutes from the heart of Melbourne's city centre. Auscarts...
Westgate Park offers a range of attractions and activities within close proximity to the city. Located along the eastern banks of the Yarra River...
Follow the aromas of freshly extracted single origin coffee beans down cobblestoned laneways and into laid-back coffee strips for that caffeine buzz.
Make the most of Melbourne's long hot summer and plentiful onshore winds and try your hand at sailboarding or kitesurfing at popular beach spots.
Melburnians love their pubs almost as much as they love their footy. And with imaginative pub grub, sunny beer gardens and killer live music, what's not to love?
Melbourne is a melting pot of cultures, a fact reflected in its restaurants, cafes, bistros and bars. Feast on a dizzying spread of the world's great cuisines.
Make the most of the rivers, parks and coastline Melbourne has to offer with a range of outdoor activities to suit your interests and lifestyle.
Live your own love story with a weekend of indulgence in Melbourne. Revel in luxury, take a balloon flight at dawn, and see masterworks at the NGV.
See all that Melbourne has to offer with the knowledge of a local. Discover laneway boutiques, theatre shows, galleries and the best places to eat.
Pack your bags for the weekend and sate your appetite for good food, wine and design as you explore the best places to shop, dine and enjoy a tipple.
Don't waste a single moment of your weekend break wondering what to do. Use our two-day guide and uncover the city's cultural and artistic heart.
Did you not find what you are looking for? Try our specialised searches:


text:
Bank Branches Locators
Bank Branches Locator Display locations and telephone numbers of branches throughout the country of Thai commercial banks. The locations in Bangkok will be displayed by zones and streets while those in provincial area will be displayed by provinces as well as the separated displays on various tourist destinations for tourist visitors coming to Thailand.
Bangkok Bank
Bank of Ayudhya
Siam Commercial Ba
Bank Thai
TMB Bank
Krung Thai Bank
UOB Bank
Kiatnakin Bank


text:
Frame Material Details: Fiber | Style: Coastal |
Frame Material: Other | Woven: Yes |
Woven Material: Wicker | Weather Resistant: All weather |
Shape: Round | Cushions Available: Yes |
Cushions Included: Yes | Upholstery Material: Sunbrella |
Questions & Answers
Kingsley Bate Carmel Ottoman with Cushion
Kingsley Bate Ottoman Lynne Becher from Syracuse NY Quality is above what I expected. Matches my chair perfectly. I was worried about the match because I have had the chair for 4 years, and they are not a set.looks great in my family room. Came sooner than expected. Very happy with the purchase.would tell a friend. |
As America's leading manufacturer of teak outdoor furniture, Kingsley-Bate uses only premium quality teak and precise mortise and tenon joinery in the construction of our furniture. Kingsley-Bate is the first American company to use Javanese teak in the manufacture of its furniture.
Kingsley-Bate teak is harvested from carefully controlled plantations, established in Indonesia by the Dutch in the Mid-19th century. Simply put, Kingsley-Bate sets the standard for quality, value and design innovation that other companies follow.


text:
Tuesday, March 11, 2014 | 4:38 a.m.
Hi, (not you?) | Member Center | Sign Out
The Downtown Dayton Lions Club held its' 43rd annual Christmas with Special Friends luncheon Thursday at the Presidential Banquet Center in Kettering. Forty-five Dayton Public Schools students who are visually impaired or have a disability attended with their parents or caregiver. The highlight of the event was a visit from Santa Claus who had a gift for each child. PHOTO BY LISA POWELL
© 2014 Cox Media Group. By using this website,
you accept the terms of our Visitor Agreement and Privacy Policy, and understand your options regarding Ad Choices.
This station is part of Cox Media Group Television
Already have an account? Sign In
{* #registrationForm *} {* traditionalRegistration_displayName *} {* traditionalRegistration_emailAddress *} {* traditionalRegistration_password *} {* traditionalRegistration_passwordConfirm *}Already have an account? Sign In
{* #registrationFormBlank *} {* registration_firstName *} {* registration_lastName *} {* traditionalRegistration_displayName *} {* traditionalRegistration_emailAddressBlank *} {* registration_birthday *} {* registration_gender *} {* registration_postalZip *} {* traditionalRegistration_passwordBlank *} {* traditionalRegistration_passwordConfirmBlank *} {* agreeToTerms *}We have sent you a confirmation email. Please check your email and click on the link to activate your account.
We look forward to seeing you frequently. Visit us and sign in to update your profile, receive the latest news and keep up to date with mobile alerts.
Don't worry, it happens. We'll send you a link to create a new password.
{* #forgotPasswordForm *} {* forgotPassword_emailAddress *}We have sent you an email with a link to change your password.
We've sent an email with instructions to create a new password. Your existing password has not been changed.
To sign in you must verify your email address. Fill out the form below and we'll send you an email to verify.
{* #resendVerificationForm *} {* resendVerification_emailAddress *}Check your email for a link to verify your email address.


text:
Adding Rice Cereal to baby formula..
My daughter was 9 lbs and 14.7 oz when she was born. She is only 2 months old but EVERYBODY is telling me I need to add rice cereal to her make. The make fun of me because I disagree with them saying that I'm starving my baby. But, I don't see the benefit of adding rice cereal to her milk othere than her sleeping more through the night. But, I want her to wake up when she's hungry. I also learned that all I'm doing is adding fat cells to her stomach by adding the rice cereal. Why is Rice cereal so important or common, other that making the food sit on their stomach longer so they wont eat as much?
Posted: 12/17/2007 by Sheresenicolle
Mom Answers
Sort by:
best answers | most recent answers
1 -
10 of
61 answers
My daughter was born at 26 weeks - exactly 3 months early- and has been having feeding problems since NICU . She does projectile vomiting at least once a day. She just turned 2 months old adjusted and I asked the doctor what u could do to help her vomiting since I was scared of dehydration. Dr switched the formula to Enfamil AR ( added rice starch). First day was a bliss - she pooped twice which is something I've never seen with her ( she poops once every 3 days ) . By the end of the first 36 hours on the new formula my daughter became fussy an cried unconsolably and wanting food every hour until she finally vomited every bit of formula that was is her tummy . Right then and there I stopped the new formula and went back to Similac Neosure. Cryposted 01/16/2014 by JulietaAngova
I was told only too add because normal formula want giving my baby enough calories if your baby is growing fine leave it out your pediatrician should till you when to add itposted 10/28/2013 by a BabyCenter Member
I always like to read 2 sides to everything and I found this while seeing if maybe my baby was a good candidate for adding rice cereal to her formula. http://guggiedaly.blogspot.com/2012/11/the-aftermath-of-introducing-rice.html?m=1 Just to be on the safe side I would keep a good eye on your baby if you try it.posted 10/18/2013 by armygirlfriend615
My son is 11 weeks old and he has had problem pooping ever since he was a week. We tried so many different types of formulas and it just made him sick plus certain tricks from the dr. Finally my mom told me to put 1tsp to every 4 oz. Not only does it help his bowls he eats better and is not as fussy. He doesn't over sleep. I'm a new mom and was reading all the books and on the phone with my pediatrician all the time. He was 9lbs 1oz when he was born and is 54% in wieght. As long as he's happy and healthy that's all that mattersposted 09/16/2013 by a BabyCenter Member
My baby is 16 weeks and not on rice. He does want to eat 5 to 6 oz every 2 to 4 hours. He sleeps about 8 hours straight at night. He sometimes fusses like babys do but is healthy and happy. If your baby is healthy an happy your doing something right for your baby. As the old saying goes 'if it's not broken don't fix it'. I would ask your baby's doctor first, and tell everyone to stop telling you how to raise your baby. Good luck!posted 08/07/2013 by kimberlistephens11
You are right to be hesitant. There is no reason babies should have rice cereal at all, it is just a cultural tradition in some westernized countries. And as you say, it just adds empty calories they don't need. When it is really time to add food (and there's no rush), there is a whole world of veggies, meats, and fruits to start with that taste a whole lot better!posted 04/03/2013 by sweetelismom
Prevents spitting up frequentlyposted 01/07/2013 by shellyv77
My 17 day old son is on a little rice in his bottle during the day and nursing at night because he has acid reflux and is aspirating the milk into his lungs when its too thin. Breast milk absorbs into the lung without serious problems because its a biological human liquid. I do give him water once a day because of the cereal. He's doing much better!posted 12/17/2012 by kaynaburrows12
Please remember that every baby is different! While your pediatrician is a great resource you know your baby. If your baby is doing fine on just formula so be it but some babies need a little more. I have a 2 month old and just started adding a little rice cereal to his formula. He was eating 5-6 oz every three hours then would spit up so easily. Since adding the cereal he is much happier and cleaner. Rice is such a simple thing I think it's better than trying a million different formulas or even worse medicines. Remember you should do what's works for you and your baby. Don't be so hung up on specific months to do things.posted 12/16/2012 by sassynurse08
My baby girl was 11lbs 3oz and 22.5 inches long at birth. She's 6 weeks old today. I was feeding her 6 oz of formula (per doctors orders) and she was not satisfied and never slept more than 2 hours. So my hubby and I started rice cereal in her bottles. She has 4 oz (with rice) and is satisfied. She sleeps ALL night from 9pm to 8am.posted 11/30/2012 by AmiyasMama
Answer this question


text:
Artist: | Cobe Obeah |
Title: | Dark Night |
Album: | Song of the Starz 2: Dark Night |
Producer: | Farbod |
Avg Rating: |
If Adele was the new Imogen Heap, could Florence Welch (of "and the Machine" fame) be the new Adele? After a listen to Cobe Obeah's latest single, I'm thinking she's a prime candidate for hip-hop's next across-the-pond musical crush. On his latest mixtape selection, the Los Angeles native (and Read More


text:
Sunday, November 16, 2008
© Copyright 2014
Gwinnett Daily Post
WINDER - Book worms of Barrow County rejoice! Each library in your county is now open more hours every day.
Leaders with the public libraries of Winder, Auburn and Statham recently announced the facilities will be open a combined 33 extra hours per week. "These increases allow Barrow residents better access to their facilities and resources," said Alan Harkness, director of the Piedmont Regional Library System. The longer hours are possible because all three cities recently increased their respective library revenue streams - especially in Winder, where the library coffer was beefed up 150 percent, said Harkness. "Five of the six funding agencies in Barrow County have increased their operating support for libraries," he said. Each of Barrow's libraries is a member of the three-county, 11-library Piedmont Regional Library System, which serves Banks, Barrow and Jackson counties, Harkness said. The new hours are as follows: · Auburn: Monday 11 a.m. to 8 p.m.; Tuesday to Thursday, 11 a.m. to 7 p.m.; Friday and Saturday, 11 a.m. to 3 p.m. · Winder: Monday, 9 a.m. to 8 p.m.; Tuesday, to Thursday, 9 a.m. to 7 p.m.; Friday, 9 a.m. to 5 p.m. and Saturday, 9 a.m. to 3 p.m. · Statham: Monday, 10 a.m. to 6 p.m.; Tuesday, and Wednesday, 10 a.m. to 5 p.m.; Thursday, 10 a.m. to 7 p.m.; Friday, 1 p.m. to 5 p.m. and Saturday, 10 a.m. to 1 p.m.More like this story
- Barrow County school board to consider library funds request ( May 21, 2008 )
- Budget woes force Winder's library to reduce hours
Board votes to close on Fridays, Sundays ( August 5, 2007 ) - Library system hires new regional director ( November 19, 2006 )
- New managers chosen for Auburn, Winder libraries ( June 9, 2007 )
- Eight candidates seeking two seats in Statham ( October 28, 2009 )


text:
Mac 'N' Cheese Salad Recipe
"This salad is so easy to make, and it tastes even better the next day," assures Doris Moore of Augusta, Illinois. Extra macaroni and cheese is the key to the cool creamy mixture that's seasoned with a pinch of dill.
- 1-1/2 cups leftover macaroni and cheese, chilled
- 1/2 cup chopped cucumber
- 1/4 cup sliced radishes
- 1/4 cup mayonnaise
- 2 tablespoons chopped onion
- 1/2 teaspoon ground mustard
- 1/8 teaspoon dill weed
- In a serving bowl, combine all of the ingredients. Serve immediately. Yield: 2-3 servings.
Originally published as Mac 'N' Cheese Salad in Quick Cooking
July/August 2004, p52
Reviews for Mac 'N' Cheese Salad(0)
Please Log In or Join to add a rating and review.
Click stars to rate
Any changes to your rating or review will appear where you originally posted your review


text:
Heatherdale provides some fine looking point'n'click adventuring from the same people who brought you the equally fine Morningstar last year [subbed by zen].
Entry 4268, Friday, April 2nd 2010, Filed In Games
Rating(52%) Comments(31)
Whilst it might be everybody's dream to be locked in a toy factory (ok, so maybe I might be projecting ever so slightly), if you don't Escape The Toy Factory sharpish you're going to get torn limb from limb and get used in the construction of the toys. There's motivation for you [subbed by BReal].
Entry 4267, Friday, April 2nd 2010, Filed In Games
Rating(54%) Comments(6)
Trying to play Alloy is really difficult. Not because of the puzzles or the language barrier, although I guess both might be a bit of a problem at some point, the main issue is that's it's so tricky to accurately point'n'click whilst simultaneously grooving on down to the soundtrack [subbed by Cyberjar88 & Liekster].
Entry 4266, Friday, April 2nd 2010, Filed In Games
Rating(65%) Comments(11)
We all love an ice cold glass of Melonade, but I'm not so sure about the supermarket own-brand beverage involved in Melonsoda Juice Room Escape [subbed by Cyberjar88].
Entry 4265, Friday, April 2nd 2010, Filed In Games
Rating(50%) Comments(7)
Once In A Blue Moon squeezes some simple(ish) puzzles into a short, but sweet, package for you to point'n'click your way thru [subbed by zen].
Entry 4264, Wednesday, March 31st 2010, Filed In Games
Rating(52%) Comments(13)
Entry 4263, Wednesday, March 31st 2010, Filed In Games
Rating(65%) Comments(12)
Curiously enough most of my day time nightmares, "daymares" if you will, revolve around the release of Daymare Town 3 being pushed back for some reason, and thus being stuck with yet more badly written pixel hunting nonsense for another six months, but huzzah and hurrah, my fears were unfounded, and it's here. The only question is, what shall I worry about now? Is it too early to ponder DMT4 I wonder? [subbed by Murtaugh, myuhinny, Cyberjar88, Chacha, Mimi & Daremaster Spoodle].
Entry 4262, Tuesday, March 30th 2010, Filed In Games
Rating(64%) Comments(66)
Chewie The Chewitsaurus Spaceship Game demonstrates what we all knew would happen; after Pigs In Space it was only a matter of time before we had Dragons In Space.
Entry 4261, Tuesday, March 30th 2010, Filed In Games
Rating(66%) Comments(7)
I'm not saying Chewie The Chewitsaurus Castle Adventure Game is easy, but playing it is like taking candy from a dragon.... well okay, maybe that's a bad example. Taking candy from dragons can be tricky sometimes, as we all know, especially if they have low blood sugar levels, but that doesn't stop the fact that this is a simple little point'n'clicker designed for kids
[subbed by Mike Anderson].
Entry 4260, Tuesday, March 30th 2010, Filed In Games
Rating(76%) Comments(4)
The dubious fact fans amongst you will be pleased to learn, if you didn't know already, that the soundtrack, and title, for Dinx - School Spirit, are actually derived from the last tune that Nirvana rejected before coming up with Smells Like Teen Spirit [subbed by myuhinny].
Entry 4259, Tuesday, March 30th 2010, Filed In Games
Rating(64%) Comments(9)
Sleepyhead offers you a fistful of puzzles to solve as you you try to return from limbo, between life and death, after being hit by a car... as you can imagine it's not exactly easy, even if the specifics are not exactly what you would expect [subbed by myuhinny].
Entry 4258, Tuesday, March 30th 2010, Filed In Games
Rating(38%) Comments(7)
The Treasure Hunter is, improbably, a cute little blue ball, that you help roll and bounce around the screen in his quest for riches [subbed by myuhinny].
Entry 4257, Sunday, March 28th 2010, Filed In Games
Rating(41%) Comments(8)
Site Search
Popular Posts
Blasts From The Past
56K Modem EmulatorSpring Breeze(15)
Escape From A Railwa...(23)
50 Comedies(53)
Pool Room Escape(24)
Chika Escape(53)
Toya Room(12)
Lotus Root Room Escape(17)
Toya Room 2(38)
Escape From A Railwa...(23)
50 Comedies(53)
Pool Room Escape(24)
Chika Escape(53)
Toya Room(12)
Lotus Root Room Escape(17)
Toya Room 2(38)
More Games
1001 Juegos
123 Bee
Arcade Games
Bonte Games
Coffre à Jouets
Escape Games 24
Flash Gamez
Free Games News
Games Handbook
Inka Games
Jay Is Games
Juegos De Escape
Mix Games 1
No.1 Game
Pastel Games
Pencil Kids
Planet Freeplay
Rooms 2 Escape


text:
Nature's Answer Passionflower Herb -- 2 fl oz
Passion Flower
this is an awesome product, really helps you sleep!
November 8, 2013
it works!
I had read about passionflower and was excited to find it at such a reasonable price, i definitely notice a sounder sleep, without waking in the middle of the night, and no "hangover" whatsoever.
August 27, 2013
helps me sleep
August 4, 2013
Works well
My husband has always had trouble sleeping. This allows him to fall asleep faster and sleep more soundly while having no side effects.
May 11, 2013
Easy to take liquid
Helps provide relaxation necessary for easily drifting off to sleep.
September 23, 2012


text:
Joby: Gorillapod SLR
Our Price: $39.95
The Gorillapod SLR features sturdy prehensile legs that help you get a steady shot in virtually any environment. Its compact size means it can go anywhere and everywhere, and the quick-release plate makes setup a snap. Whether you're shooting time-lapse photos with your SLR or capturing videos with your camcorder, the Gorillapod SLR is the perfect companion to your next great adventure.
- Slim-line attachment stays connected to your camera for nearly instant setup
- Lock ring enables extra security to ensure your camera is safely attached
- Flexible joints bend and rotate 360 degrees to form the perfect shape
- Ring and foot grips provide extra gripping power to grapple wherever you go
Intended for: | Lightweight SLR cameras and camcorders |
Max weight load: | 1.75 lb |
Adapter: | Universal 1/4-in screw |
Size: | 250 x 50 x 50 mm |
Weight: | 5.8 oz |
Habitat: | Anywhere! |


text:
Microsoft Surface RT priced at $499 or $599 with Touch Cover keyboard
Microsoft finally names its Surface price
After announcing its Surface tablets nearly four months ago, Microsoft has now unveiled the pricing for both of its ARM-based Surface RT tablets at its Microsoft online stores. The 10.6-inch Surface, powered by Windows RT, will go on sale on October 26th and will be priced starting at $499 for the 32GB version without Touch Cover and a 32GB version with the Touch Cover for $599. Microsoft is also offering 64GB model for $699 with a Touch Cover included. The 9.3mm thin tablet weighs just 1.5lbs and includes a built-in kickstand and vapor-deposited (PVD) magnesium case.
Microsoft listed its Surface pricing at its online Microsoft Store this morning, indicating that pre-orders will be available shortly. The company has also listed the prices for its Touch Cover, at $119.99 each, and Type Cover for $129.99. The Touch Cover appears to be available in white, red, black, blue, and purple colors – while the Type Cover is listed as a single item in black.
Microsoft's advertising campaign for its Surface devices has already kicked off, with Surface street art spotted in a number of US cities over the past few weeks. The software maker will hold a Surface reception event for press and analysts on October 25th, and some of the company's holiday pop-up stores will open at midnight on October 26th to start selling the tablets.
Update: Microsoft's online store listing has now gone offline.
Surface RT now available for pre-order in eight countries
Under the Surface: an inside look at how Microsoft's tablet came to be
Thanks, urosmiklavcic!


text:
Heart Disease: What Are the Medical Costs?
Heart disease can affect more than your health. It can have an impact on your finances, too.
Here's a rundown of the costs of heart disease -- and some advice about how you can protect your wallet.
Keeping Seniors Safe in Their Own Homes
Does your home seem less accommodating than it used to? Join the club. That tends to happen as we age. Toilets are suddenly too low, cabinets too high, and steps and loose rugs make getting around perilous, especially if you have stiff, arthritic joints. Karen Kassik discovered this in 2002, when she brought her then 66-year-old mother to live in her two-bedroom home in Winter Park, Fla. "I found out very quickly how inadequate this little house was," she recalls. Kassik, 45, used her background...
Read the Keeping Seniors Safe in Their Own Homes article > >
The High Cost of Heart Disease
In 2010, the cost of cardiovascular disease in the U.S. was about $444 billion. That includes costs for treatment of:
- Heart conditions
- Stroke
- Peripheral artery disease
- High blood pressure
Treatment of these diseases accounts for $1 of every $6 spent on health care in the U.S.
Direct medical costs. After a heart attack, there are immediate charges, such as:
- Ambulance
- Diagnostic tests
- Hospital charges
- Possible surgery
Long-term maintenance of heart disease is also expensive. The costs include:
- Drugs
- Testing
- Cardiologist appointments
Indirect costs. The largest indirect costs are lost productivity and income, though many people may be able to return to work a few months after having a heart attack.
Protecting Yourself From the Medical Costs of Heart Disease
Here's what you can do to protect yourself and your family from the financial costs of heart disease:
Look into cheaper medication. Ask your doctor or pharmacist if there are generic substitutes that might work as well but cost less. Many drug companies also offer assistance programs that will get you discounted medication.
Check your health insurance policy. "The most important thing you can do to protect yourself is make sure that you have adequate health insurance," says cardiologist Paul A. Heidenreich, MD, associate professor of medicine at Stanford University. Learn exactly what your policy covers.
The health care reform law will prevent insurers from declining coverage because of heart disease or other preexisting conditions. This will be enforced beginning in 2014.
Consider disability insurance. If you're healthy now, getting disability insurance could be a smart idea. It will replace some of your lost income if you ever become disabled by heart disease or another condition and can't work.
If you've already had a heart attack or heart disease diagnosis, getting disability insurance will be more difficult and cost more. Some policies could still be available but they might exclude any health problems related to heart disease.
Preventing and Treating Heart Disease
You can help cut your risk of heart disease -- and the medical costs that go with it -- by making lifestyle changes. Even if you've already developed heart disease, it's not too late. Lifestyle changes can still have a big impact, Heidenreich says.
Try these tips:
Get more physical activity. Regular exercise can help you:
- Lower blood pressure
- Improve cholesterol levels
- Control weight
- Lower your risk of heart disease
The American Heart Association recommends at least 150 minutes of moderate physical activity each week. That could be 30 minutes of moderate-to-vigorous exercise -- such as brisk walking or biking -- five days a week.


text:
Police say a man sexually assault a woman during Tuesday's Iron Maiden and Megadeth concert at Walnut Creek.
Josue Hernandez, 20, was arrested Tuesday and charged with sexual battery and resisting a public officer.
Police said Hernandez groped a 24-year-old woman during Tuesday night's Iron Maiden and Megadeth concert at the Walnut Creek Ampitheater in Raleigh.
Hernandez and the victim did not know each other, police said.
1336 Augusta West ParkwayAugusta, GA 30909
Telephone: 706.722.6664 Email: email@example.com


text:
Forums >Health and Nutrition>Running after a groin injury
I don't see any reason to run with pain, you're only hurting yourself in the long run by risking making the injury worse. Give it another week. Runners often have weak hip/groin areas. Improving your general strength will help you run more with less injury. I just cured myself (halleluja!) through some localized long term groin pain by doing a lot of the exercises in this vid a few times a week. http://youtu.be/yXpK3bF9UlA
© 2014 RunningAHEAD, LLC. All rights reserved. | Terms of Service | Privacy